CLINICAL_TRIALS
trial_result
· 2021-05-05
Clinical Trial Update: Efficacy and Safety of Plasma Exchange With Albutein® 5% in Participants With Amyotrophic Lateral Sclerosis [Phase 2]
Summary
Phase 2 trial assessing plasma exchange with Albutein 5% for efficacy and safety in amyotrophic lateral sclerosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Grifols Therapeutics LLC | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2021-05-05